{"id":"https://genegraph.clinicalgenome.org/r/6348ecca-18fc-4cc3-9817-61448031a1b9v1.0","type":"EvidenceStrengthAssertion","dc:description":"ANK2 encodes Ankyrin2, a protein important for localization and membrane stabilization of cardiac ion channels. This gene is located within a very large (~16 million bp) region identified by linkage analysis in a large family with LQTS (PMID 7485162). Subsequent sequencing of ANK2 in members of this family identified a missense variant (p.Glu1458Gly) that at time of publication (2003, PMID 12571597) was thought to be pathogenic. Contemporary data, however, demonstrates this variant has a population frequency too high for an autosomal dominant cause of LQTS (~1:400 individuals of Latino ancestry). Due to lack of other segregation data or case-control data and paucity of additional genetic and experimental data, this gene-disease association was classified as disputed.\nNote: All LQTS genes were curated by 3 separate blinded teams. The evidence and scores reached by these 3 teams was reviewed by the LQTS Clinical Domain Working Group. The classification and summary presented here is the conclusion of this Working Group's analysis according to evidence available at time of publication. The scores presented here are the result of only one of the three curation teams' efforts. For a detailed discussion of this group's work and the scores of all 3 teams please see \"Adler et al. An International, Multicentered, Evidence-Based Reappraisal of Genes Reported to Cause Congenital Long QT Syndrome. Circulation 2020;141(6):418-428. doi: 10.1161/CIRCULATIONAHA.119.043132”","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/6348ecca-18fc-4cc3-9817-61448031a1b9","GCISnapshot":"https://genegraph.clinicalgenome.org/r/dd577817-d668-413c-95f9-d3e08a8cf5d3","calculatedEvidenceStrength":"Limited","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/dd577817-d668-413c-95f9-d3e08a8cf5d3_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10025","date":"2020-12-15T00:27:19.834Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/dd577817-d668-413c-95f9-d3e08a8cf5d3_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10025","date":"2020-12-22T02:49:42.263Z","role":"Publisher"}],"curationReasonDescription":"See evidence summary","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dd577817-d668-413c-95f9-d3e08a8cf5d3_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dd577817-d668-413c-95f9-d3e08a8cf5d3_ad_other_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7bb0976d-7a24-4adb-b584-856ae88e45f2_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3e57f0a9-3698-4baa-bca2-3e10c4e03c39","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26132555","rdfs:label":"LQT4 - 3","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001663","obo:HP_0001657"],"previousTesting":true,"previousTestingDescription":"\"known LQTS genes\"","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/7bb0976d-7a24-4adb-b584-856ae88e45f2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26132555","allele":{"id":"https://genegraph.clinicalgenome.org/r/c8e66329-1ecf-49c0-ab1c-ab956260c923","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001148.6(ANK2):c.6149T>C (p.Ile2050Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/207943"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/345f36dd-8ce7-4e7b-ba33-d740b73e9626_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/82f8244f-0436-4c57-ac83-b1410fc4fac9","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28196901","rdfs:label":"Individual 1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":34,"detectionMethod":"NGS clinical testing panel for LQTS (12 genes)","ethnicity":{"id":"cg:NotHispanicOrLatino"},"phenotypes":["obo:HP_0001279","obo:HP_0005184"],"previousTesting":true,"previousTestingDescription":"Clinical panel for LQTS (12 genes)","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/345f36dd-8ce7-4e7b-ba33-d740b73e9626_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28196901","allele":{"id":"https://genegraph.clinicalgenome.org/r/7ba5a269-b8b9-4149-9ae2-7c659525eac2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001148.6(ANK2):c.1937C>T (p.Ser646Phe)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/190552"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/5cddd43d-d083-4ef9-87c4-f6d12cd7a5ea_proband_score_evidence_line","type":"EvidenceLine","dc:description":"The QTc had normalized at 4mo of age. QT prolongation only observed during bradycardia.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e62bffff-0bbd-4325-9b0b-9985f470cf06","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27784853","rdfs:label":"Patient 1","ageType":"AgeAtOnset","ageUnit":"Days","ageValue":1,"detectionMethod":"WES + sanger confirmation","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"female newborn with marked bradycardia, high-grade AVB and QT prolongation (QTc 532 ms). At 4 months  no longer AVB and long QT (433 ms) but still bradycardia.","phenotypes":["obo:HP_0011708","obo:HP_0001662","obo:HP_0001657"],"previousTesting":true,"previousTestingDescription":"sanger sequencing of KCNQ1, KCNH2, SCN5A","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/5cddd43d-d083-4ef9-87c4-f6d12cd7a5ea_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27784853","allele":{"id":"https://genegraph.clinicalgenome.org/r/3208b00e-43c1-489e-9179-8d95ab847e12","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001148.6(ANK2):c.442T>C (p.Tyr148His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA357914435"}}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/d944ee23-d013-4cba-a692-16355721d042_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7d85db0b-4a09-441e-876f-4f1d252ebdbf","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26132555","rdfs:label":"LQT4 - 2","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001657","obo:HP_0001279"],"previousTesting":true,"previousTestingDescription":"\"known LQTS genes\"","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/d944ee23-d013-4cba-a692-16355721d042_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26132555","allele":{"id":"https://genegraph.clinicalgenome.org/r/bad939de-7487-4124-924a-2bc12bd1843e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001148.6(ANK2):c.4876A>G (p.Lys1626Glu)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/207942"}}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/99a833db-4a8b-4b5c-8b69-bff13a1c838e_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cf8863c1-af0a-4c39-a78f-ef2245d36ddd","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28196901","rdfs:label":"Individual 7","ageType":"AgeAtReport","ageUnit":"Years","ageValue":43,"detectionMethod":"NGS LQTS clinical testing panel","ethnicity":{"id":"cg:NotHispanicOrLatino"},"phenotypes":["obo:HP_0005184","obo:HP_0001279"],"previousTesting":true,"previousTestingDescription":"Clinical LQTS genetic testing panel (12 genes)","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/99a833db-4a8b-4b5c-8b69-bff13a1c838e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28196901","allele":{"id":"https://genegraph.clinicalgenome.org/r/7ba5a269-b8b9-4149-9ae2-7c659525eac2"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/075ca4f9-dac7-4667-8f34-eedb637c419b_proband_score_evidence_line","type":"EvidenceLine","dc:description":"The patient had been clinically diagnosed as “atypical” or “borderline” cases of LQTS. Small number of unmatched controls (200 controls; of whom 100 were black). A high portion of the controls had another variant in ANK2  (8 of 200 controls), indicating that variants in ANK2 may be common.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2064ffd3-04c3-4f63-b9ad-49a919401c47","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16253912","rdfs:label":"Patient 2","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":8,"detectionMethod":"Polymerase chain reaction, denaturing high-performance liquid chromatography, and direct DNA sequencing.","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypeFreeText":"Long QT syndrome","previousTesting":true,"previousTestingDescription":"No mutation in KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2.","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/075ca4f9-dac7-4667-8f34-eedb637c419b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16253912","allele":{"id":"https://genegraph.clinicalgenome.org/r/60641ace-ea84-402f-9865-7678ae813e92","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001148.6(ANK2):c.4502C>T (p.Pro1501Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA3051113"}}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/6dd6d8a3-492b-4133-b0fa-cd3f02aee6ff_proband_score_evidence_line","type":"EvidenceLine","dc:description":"The segregation is not convincing.\nVariant 1 is very common in GnomAD population . Allele frequency 0.008573 and also variant 2, allele frequency in GnomAD 0.009302","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ef3f720c-2d6a-4bc6-afcd-e356cec3a582","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28003625","rdfs:label":"female, 14 yo","ageType":"AgeAtReport","ageUnit":"Years","ageValue":14,"detectionMethod":"NGS panel for 14 LQTS genes; confirmation by sanger sequencing","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"syncope and premature ventricular contractions during physical activity. QTc > 470 ms","phenotypes":"obo:HP_0001279","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/6dd6d8a3-492b-4133-b0fa-cd3f02aee6ff_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28003625","allele":[{"id":"https://genegraph.clinicalgenome.org/r/424714e9-9aa5-49ad-b5ab-e5cd57ba43e3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001148.6(ANK2):c.9854T>C (p.Ile3285Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA199899"}},{"id":"https://genegraph.clinicalgenome.org/r/0b351e48-e8fa-47af-b508-206f2c42b6c0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000219.6(KCNE1):c.253G>A (p.Asp85Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA123130"}}]}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/056e0bf7-35f7-4fe2-96e4-35a49eeeb935_proband_score_evidence_line","type":"EvidenceLine","dc:description":"MAF 0.013 in Europeans","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fb1edc27-fee8-4d48-9164-329d34bb379b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15178757","rdfs:label":"Patient 2 with the T1626N mutation","ageType":"AgeAtReport","ageUnit":"Years","ageValue":51,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/056e0bf7-35f7-4fe2-96e4-35a49eeeb935_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15178757","allele":{"id":"https://genegraph.clinicalgenome.org/r/dd709736-bef1-4bc3-a394-e71ad2c912ba","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001148.6(ANK2):c.11231C>A (p.Thr3744Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA145030"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/eaf1629a-7ea1-4aae-91eb-1ded3097ccaa_proband_score_evidence_line","type":"EvidenceLine","dc:description":"The variant is common in the East Asia (Allele Freq:0.0004065), whereas very rare in the other population (allele frequency 0.00002847)","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/29b2fb3b-c313-4386-a634-9b5143096cf7","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16864073","rdfs:label":"72 yo woman","ageType":"AgeAtReport","ageUnit":"Years","ageValue":72,"detectionMethod":"PCR+SSCP; confirmation by sanger sequencing and RFLP","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","previousTesting":true,"previousTestingDescription":"screening for other 6 LQTS genes (SSCP)","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/eaf1629a-7ea1-4aae-91eb-1ded3097ccaa_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16864073","allele":{"id":"https://genegraph.clinicalgenome.org/r/f846aea7-b33f-4911-bfba-129c3368cb8a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001148.6(ANK2):c.10858T>A (p.Trp3620Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA300933"}}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/88630ad8-45cc-48bc-a7b5-5eba907b52c7_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Likely aqcuired LQTS","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/59f96c4b-19c0-4893-a5b5-482ee73b83dc","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27784853","rdfs:label":"Patient 6","ageType":"AgeAtReport","ageUnit":"Years","ageValue":36,"detectionMethod":"WES + sanger confirmation","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Admitted in emergency hospital for nausea and vomiting: lost consciousness because of TdPs.QTc 597ms. The day after QTc was 445 ms","phenotypes":["obo:HP_0001657","obo:HP_0001279"],"previousTesting":true,"previousTestingDescription":"sanger sequencing of KCNQ1, KCNH2, SCN5A","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/88630ad8-45cc-48bc-a7b5-5eba907b52c7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27784853","allele":{"id":"https://genegraph.clinicalgenome.org/r/f846aea7-b33f-4911-bfba-129c3368cb8a"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/25076235-7738-4cf3-af04-55783ab5e4ff_proband_score_evidence_line","type":"EvidenceLine","dc:description":"MAF 0.019 in Ashkenazi Jews","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bfc1bb93-19fc-45c7-aa8d-b85c76fe2b09","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15178757","rdfs:label":"Patient 1 with the E1813K mutation","ageType":"AgeAtReport","ageUnit":"Years","ageValue":24,"detectionMethod":"All exons of ankyrin-B (Ank2), with exception of brain-specific exon 38, were screened by single-strand conformation polymorphism (SSCP) or by denaturing HPLC, and DNA sequence analyses.","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"SSCP","phenotypeFreeText":"Prolonged T interval and torsades de pointes","phenotypes":"obo:HP_0001657","previousTesting":true,"previousTestingDescription":"No mutation in KCNQ1, HERG, SCN5A, KCNE1, KCNE2, and KCNJ2.","secondTestingMethod":"Denaturing gradient gel","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/25076235-7738-4cf3-af04-55783ab5e4ff_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15178757","allele":{"id":"https://genegraph.clinicalgenome.org/r/2b27ebd8-e5d1-4add-b2cc-33f06a71d0f1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001148.6(ANK2):c.11791G>A (p.Glu3931Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA145040"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/6f5db2c0-3962-41ab-a8e1-310a76e7bff1_proband_score_evidence_line","type":"EvidenceLine","dc:description":"The patient had been clinically diagnosed as “atypical” or “borderline” cases of LQTS. Small number of unmatched controls (200 controls; of whom 100 were white). A high portion of the controls had another variant in ANK2  (8 of 200 controls), indicating that variants in ANK2 may be common.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/746da643-e822-4f18-9d1f-3eaf323720be","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16253912","rdfs:label":"Patient 1","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":14,"detectionMethod":"Polymerase chain reaction, denaturing high-performance liquid chromatography, and direct DNA sequencing.","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"PCR","phenotypeFreeText":"Long QT syndrome","phenotypes":"obo:HP_0001657","previousTesting":true,"previousTestingDescription":"No mutation in KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2.","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/6f5db2c0-3962-41ab-a8e1-310a76e7bff1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16253912","allele":{"id":"https://genegraph.clinicalgenome.org/r/97fee2fd-90e2-4db9-b1c0-1c8be4d5c582","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001148.6(ANK2):c.4351A>G (p.Thr1451Ala)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA357913432"}}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/0e1fb489-d25a-47a9-bc5c-ec5e7438f4b8_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Glu1425Gly, now known as p.Glu1458Gly has a MAF on 0.0012 in Latino/admixed American population","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/befb6a9f-405e-454e-a0cc-3951a2b7e06a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15178757","rdfs:label":"Patient 1 with the E1425G mutation","ageType":"AgeAtReport","ageUnit":"Years","ageValue":28,"detectionMethod":"All exons of ankyrin-B (Ank2), with exception of brain-specific exon 38, were screened by single-strand conformation polymorphism (SSCP) or by denaturing HPLC.","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"SSCP","phenotypeFreeText":"QTc prolongation and sudden cardiac death in the family (patient herself had no phenotype)","phenotypes":"obo:HP_0001657","previousTesting":true,"previousTestingDescription":"No mutation in KCNQ1, HERG, SCN5A, KCNE1, KCNE2, and KCNJ2.","secondTestingMethod":"Denaturing gradient gel","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/0e1fb489-d25a-47a9-bc5c-ec5e7438f4b8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15178757","allele":{"id":"https://genegraph.clinicalgenome.org/r/03044674-e933-4fb6-9025-abf275491636","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001148.6(ANK2):c.4373A>G (p.Glu1458Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA127763"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/1e9819ef-4cb3-49aa-9e9a-331bb78bb84f_proband_score_evidence_line","type":"EvidenceLine","dc:description":"The patient had been clinically diagnosed as “atypical” or “borderline” cases of LQTS. Small number of unmatched controls (200 controls; of whom 100 were white). A high portion of the controls had another variant in ANK2  (8 of 200 controls), indicating that variants in ANK2 may be common.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/67bcc11e-950b-43b0-b5b4-182a4ec11836","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16253912","rdfs:label":"Patient 3","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":8,"detectionMethod":"Polymerase chain reaction, denaturing high-performance liquid chromatography, and direct DNA sequencing.","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypeFreeText":"Long QT syndrome","phenotypes":"obo:HP_0001657","previousTesting":true,"previousTestingDescription":"No mutation in KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2.","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/1e9819ef-4cb3-49aa-9e9a-331bb78bb84f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16253912","allele":{"id":"https://genegraph.clinicalgenome.org/r/d4773df9-cff1-4e56-9f01-c62ba61216a9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001148.6(ANK2):c.5166T>C (p.Ser1722=)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA440877291"}}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/33c9b8ab-0087-446c-8603-4722fcaa4945_proband_score_evidence_line","type":"EvidenceLine","dc:description":"MAF 0.0019 in Europeans","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/40e3c5b2-a884-422c-81ed-c7e71693fc89","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15178757","rdfs:label":"Patient 1 with the R1788W mutation","ageType":"AgeAtReport","ageUnit":"Years","ageValue":37,"detectionMethod":"All exons of ankyrin-B (Ank2), with exception of brain-specific exon 38, were screened by single-strand conformation polymorphism (SSCP) or by denaturing HPLC, and DNA sequence analyses.","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"SSCP","phenotypeFreeText":"Prolonged QT interval and torsades de pointes","phenotypes":"obo:HP_0001657","previousTesting":true,"previousTestingDescription":"No mutation was found in KCNQ1, HERG, SCN5A, KCNE1, KCNE2, and KCNJ2.","secondTestingMethod":"Denaturing gradient gel","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/33c9b8ab-0087-446c-8603-4722fcaa4945_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15178757","allele":{"id":"https://genegraph.clinicalgenome.org/r/c46df0b0-7c09-4f59-a1df-068897edc470","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001148.6(ANK2):c.11716C>T (p.Arg3906Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA127768"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/a3ca4bd3-42a2-4d21-b572-470fb1450fd3_proband_score_evidence_line","type":"EvidenceLine","dc:description":"MAD 0.0019 in Europeans","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e1c8edba-073b-4672-94c1-626143b962b3","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15178757","rdfs:label":"Patient 2 with the R1788W mutation","ageType":"AgeAtReport","ageUnit":"Years","ageValue":35,"detectionMethod":"All exons of ankyrin-B (Ank2), with exception of brain-specific exon 38, were screened by single-strand conformation polymorphism (SSCP) or by denaturing HPLC, and DNA sequence analyses.","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"SSCP","phenotypeFreeText":"QT prolongation after syncope, supraventricular and ventricular tachycardias","phenotypes":"obo:HP_0001657","previousTesting":true,"previousTestingDescription":"No mutation in KCNQ1, HERG, SCN5A, KCNE1, KCNE2, and KCNJ2.","secondTestingMethod":"Denaturing gradient gel","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/a3ca4bd3-42a2-4d21-b572-470fb1450fd3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15178757","allele":{"id":"https://genegraph.clinicalgenome.org/r/c46df0b0-7c09-4f59-a1df-068897edc470"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/10106326-2390-433b-9318-2ab4d7b20a30_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Acquired LQTS","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/285f97c1-c813-46ab-a695-53b8c1330dde","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27784853","rdfs:label":"Patient 8","ageType":"AgeAtReport","ageUnit":"Years","ageValue":45,"detectionMethod":"WES + sanger confirmation","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"multiple episodes of syncope since taking tolazoline hydrochloride for insomnia. Hospitalized for pharyngitis and treated with ceftriaxone she had syncope at rest, TdP, QTc 550 ms, notched T waves. After withdrawal of the drugs she still had prolonged QTc (450 ms)","phenotypes":["obo:HP_0001279","obo:HP_0001657"],"previousTesting":true,"previousTestingDescription":"sanger sequencing of KCNQ1, KCNH2, SCN5A","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/10106326-2390-433b-9318-2ab4d7b20a30_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27784853","allele":{"id":"https://genegraph.clinicalgenome.org/r/f846aea7-b33f-4911-bfba-129c3368cb8a"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/b085c571-cef1-42df-a332-c1bacaf9e24b_proband_score_evidence_line","type":"EvidenceLine","dc:description":"MAF 0.013 in Europeans","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f3f69bc9-acbf-49ec-a750-7895a206261d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15178757","rdfs:label":"Patient 1 with the T1626N mutation","ageType":"AgeAtReport","ageUnit":"Years","ageValue":46,"detectionMethod":"All exons of ankyrin-B (Ank2), with exception of brain-specific exon 38, were screened by single-strand conformation polymorphism (SSCP) or by denaturing HPLC and DNA sequence analyses.","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"SSCP","phenotypeFreeText":"Mild QT prolongation and sudden death in the family","phenotypes":"obo:HP_0001657","previousTesting":true,"previousTestingDescription":"No mutation in KCNQ1, HERG, SCN5A, KCNE1, KCNE2, and KCNJ2.","secondTestingMethod":"Denaturing gradient gel","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/b085c571-cef1-42df-a332-c1bacaf9e24b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15178757","allele":{"id":"https://genegraph.clinicalgenome.org/r/dd709736-bef1-4bc3-a394-e71ad2c912ba"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallAutosomalDominantOtherVariantEvidenceCriteria","strengthScore":2.4},{"id":"https://genegraph.clinicalgenome.org/r/dd577817-d668-413c-95f9-d3e08a8cf5d3_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/79651822-af68-4dde-8fe2-d31d8590822e_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28196901","rdfs:label":"Family 1","estimatedLodScore":2.41,"family":{"id":"https://genegraph.clinicalgenome.org/r/79651822-af68-4dde-8fe2-d31d8590822e","type":"Family","rdfs:label":"Family 1","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/82f8244f-0436-4c57-ac83-b1410fc4fac9"}},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":5,"phenotypes":"obo:HP_0005184","proband":{"id":"https://genegraph.clinicalgenome.org/r/82f8244f-0436-4c57-ac83-b1410fc4fac9"}},{"id":"https://genegraph.clinicalgenome.org/r/444e95a9-01ad-4a5a-ab43-85805630cfd0_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28196901","rdfs:label":"Family 2","estimatedLodScore":2.71,"family":{"id":"https://genegraph.clinicalgenome.org/r/444e95a9-01ad-4a5a-ab43-85805630cfd0","type":"Family","rdfs:label":"Family 2","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/cf8863c1-af0a-4c39-a78f-ef2245d36ddd"}},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":7,"phenotypes":"obo:HP_0005184","proband":{"id":"https://genegraph.clinicalgenome.org/r/cf8863c1-af0a-4c39-a78f-ef2245d36ddd"}},{"id":"https://genegraph.clinicalgenome.org/r/2fb171d2-3a15-416e-a733-b0cd5be4df7c_family_segregation","type":"FamilyCosegregation","dc:description":"The variant that was identified in this family (p.Glu1425Gly - now p.Glu1458Gly) is present in large population databases at a frequency that is likely too high to be considered associated with disease.\ngnomAD ALL populations: MAF=0.05% (1/967 individuals)\ngnomAD Non-Finnish Europeans: MAF=0.08% (1/656 individuals)\ngnomAD Latino: MAF=0.1% (1/451 individuals)","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12571597","rdfs:label":"Originally reported family","estimatedLodScore":6.32,"family":{"id":"https://genegraph.clinicalgenome.org/r/2fb171d2-3a15-416e-a733-b0cd5be4df7c","type":"Family","rdfs:label":"Originally reported family"},"meetsInclusionCriteria":false,"phenotype":[{"id":"obo:HP_0001688"},{"id":"obo:HP_0005110"}],"phenotypeFreeText":"junctional escape rhythm","phenotypePositiveAllelePositive":24}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/dd577817-d668-413c-95f9-d3e08a8cf5d3_cc_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/11efb14f-c8e8-44ae-97fa-a86c9c2d955e","type":"EvidenceLine","dc:description":"A relatively high portion of controls have a variant in ANK2 (more than LQTS cases actually). Overall, targeted ANK2 mutational analysis involving exons\n36, 37, and 39–46 revealed a total of 14 (10 novel) distinct nonsynonymous ANK2 variants. Six of the 14 variants were found in LQTS cases only, 3 of the 14 distinct variants were found among LQTS cases and controls, and 5 of the 14\nunique variants were found in controls only. Three variants were only discovered 3 (1.1%) of 269 genotype-negative LQTS cases (were absent in controls). However, the question is whether these are pathogenic mutations.","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/11efb14f-c8e8-44ae-97fa-a86c9c2d955e_cc_evidence_item","type":"Finding","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16253912","rdfs:label":"Targeted mutational analysis of ANK2 in LQTS and controls","caseCohort":{"id":"https://genegraph.clinicalgenome.org/r/3b3a948e-8e91-41fc-9d59-ba51b21bb34f","type":"Cohort","allGenotypedSequenced":541,"alleleFrequency":0.0166358595194085,"detectionMethod":"Polymerase chain reaction, denaturing high-performance liquid chromatography, and direct DNA sequencing.","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/11efb14f-c8e8-44ae-97fa-a86c9c2d955e_cc_evidence_item"}],"numWithVariant":9,"relatedCondition":{"id":"obo:MONDO_0002442"}},"controlCohort":{"id":"https://genegraph.clinicalgenome.org/r/a8bcdd26-8d72-49c5-a287-167e7b231112","type":"Cohort","allGenotypedSequenced":200,"alleleFrequency":0.04,"detectionMethod":"Polymerase chain reaction, denaturing high-performance liquid chromatography, and direct DNA sequencing.","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/11efb14f-c8e8-44ae-97fa-a86c9c2d955e_cc_evidence_item"}],"numWithVariant":8},"method":{"id":"cg:SingleVariantAnalysis"},"statisticalSignificanceType":"","statisticalSignificanceValueType":"Other"}],"specifiedBy":"GeneValidityCaseControlSingleVariantAnalysisCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/ced70b0c-5ecd-405b-97a0-b2cfba4c1895","type":"EvidenceLine","dc:description":"Too few cases and controls","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ced70b0c-5ecd-405b-97a0-b2cfba4c1895_cc_evidence_item","type":"Finding","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16864073","rdfs:label":"78 japanese patients","caseCohort":{"id":"https://genegraph.clinicalgenome.org/r/10e9884d-8f57-424a-b58d-dd049fa56c4b","type":"Cohort","allGenotypedSequenced":78,"alleleFrequency":0.01282051282051282,"detectionMethod":"PCR, SSCP, confirmation by sanger sequencing, RFLP","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ced70b0c-5ecd-405b-97a0-b2cfba4c1895_cc_evidence_item"}],"numWithVariant":1,"relatedCondition":{"id":"obo:MONDO_0002442"}},"controlCohort":{"id":"https://genegraph.clinicalgenome.org/r/2fe471d0-f5f6-44ea-9d22-314a4d373d4e","type":"Cohort","allGenotypedSequenced":150,"alleleFrequency":0,"detectionMethod":"PCR, SSCP, confirmation by sanger sequencing, RFLP","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ced70b0c-5ecd-405b-97a0-b2cfba4c1895_cc_evidence_item"}],"numWithVariant":0},"method":{"id":"cg:SingleVariantAnalysis"},"statisticalSignificanceType":"","statisticalSignificanceValueType":""}],"specifiedBy":"GeneValidityCaseControlSingleVariantAnalysisCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/e8c87463-8e98-4197-9ee9-ed6bec67c254","type":"EvidenceLine","dc:description":"The variants are more common in controls than in cases.","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e8c87463-8e98-4197-9ee9-ed6bec67c254_cc_evidence_item","type":"Finding","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17242276","rdfs:label":"445 LQTS individuals","caseCohort":{"id":"https://genegraph.clinicalgenome.org/r/732553bf-8087-44d8-aa1f-a5c4af622df5","type":"Cohort","allGenotypedSequenced":445,"alleleFrequency":0.01797752808988764,"detectionMethod":"PCR+TCGE (temperature gradient capillary electrophoresis) + sanger","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e8c87463-8e98-4197-9ee9-ed6bec67c254_cc_evidence_item"}],"numWithVariant":8,"relatedCondition":{"id":"obo:MONDO_0002442"}},"controlCohort":{"id":"https://genegraph.clinicalgenome.org/r/58b61375-b6e1-45fb-83ab-9d4365345ea8","type":"Cohort","allGenotypedSequenced":190,"alleleFrequency":0.03684210526315789,"detectionMethod":"PCR+TCGE (temperature gradient capillary electrophoresis) + sanger","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e8c87463-8e98-4197-9ee9-ed6bec67c254_cc_evidence_item"}],"numWithVariant":7},"method":{"id":"cg:AggregateVariantAnalysis"},"statisticalSignificanceType":"","statisticalSignificanceValueType":""}],"specifiedBy":"GeneValidityCaseControlAggregateVariantAnalysisCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallCaseControlEvidenceCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":2.4},{"id":"https://genegraph.clinicalgenome.org/r/dd577817-d668-413c-95f9-d3e08a8cf5d3_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dd577817-d668-413c-95f9-d3e08a8cf5d3_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0dc19f1f-ccfc-4aea-bf37-33e33c2d7ffa","type":"EvidenceLine","dc:description":"AnkB null mice appear to have a cardiac phenotype that may include a prolonged QT interval, but enough differences were noted between mice and humans that a lower point value was awarded","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7a22bc7e-96db-4f3c-bbd3-e0b8de08be25","type":"Finding","dc:description":"Ank2 (+/-) mice demonstrated significantly prolonged QT intervals as well as bradycardia, high degree of heartrate variability, episodes of abrupt sinus slowing","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12571597","rdfs:label":"ANK2 knockout mouse","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/dd577817-d668-413c-95f9-d3e08a8cf5d3_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d01196e9-19c5-49f2-9ee9-5847653ec278","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f9f0555c-d0af-4e01-ac6a-887bd8d14018","type":"FunctionalAlteration","dc:description":"Cells transfected at similar efficiencies but subsequent immunoblotting revealed that 2 days post transfection, steady-state ankyrin-B p.S646F levels were significantly lower than WT ankyrin-B. These data support that while the purified MBD harboring the p.S646F variant displayed normal expression, folding and stability, the full-length ankyrin-B p.S646F variant was unstable when expressed in model cardiomyocytes.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28196901","rdfs:label":"protein stability and targeting"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/256e6bbb-d2c4-4596-ba04-00997afdd40d","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7f99663e-53dd-400c-a0ac-3df86e5f06fa","type":"FunctionalAlteration","dc:description":"Each mutation abolishes the ability of ankyrin-B to restore abnormal Ca2+ dynamics and abnormal localization and expression of Na/Ca exchanger, Na/K ATPase and inositol trisphosphate (InsP3) receptor in cardiomyocytes of mice heterozygous for a null mutation in ANK2. The normal ankyrin-B (without a mutation) has the ability to restore the defects , when transfected in mice heterozygous for a null mutation in ANK2.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15178757","rdfs:label":"Rescue in mice heterozygous for a null mutation in ANK2"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/81199a5a-14de-4f01-abfb-294e4f5df4bb","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5e094588-ccec-42a7-83e6-4ae0c563a226","type":"FunctionalAlteration","dc:description":"ankyrin-B+/- neonatal cardiomyocytes displayed abnormal contraction rates and aberrant spatial/temporal patterns of Ca2+ release; they also displayed abnormal localization and expression of InsP3 receptor, Na/Ca exchanger I, Na/K ATPase expression\nThis phenotype can be reverted by wt gene transfection but not  with ANK2 variants gene transfection","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17242276","rdfs:label":"abnormal localization/reduced expression of receptors"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/0cbc743b-aa65-47c3-bd4a-dfd33204fc77","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6cc2430f-5d9d-4388-9809-a3281df8a9e0","type":"FunctionalAlteration","dc:description":"Mis-sorting of SERCA 2 and ryanodine receptor 2 in ankyrin-B (-/-) cardiomyocytes is rescued by expression of 220-kD ankyrin-B, demonstrating that lack of the 220-kD ankyrin-B polypeptide is the primary defect in these cells.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10579720","rdfs:label":"Study the role ankyrin-B in ankyrin-B (-/-) mice"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":3}],"evidenceStrength":"Disputed","sequence":1625,"specifiedBy":"GeneValidityCriteria8","strengthScore":5.4,"subject":{"id":"https://genegraph.clinicalgenome.org/r/4_7t-AXJKsc","type":"GeneValidityProposition","disease":"obo:MONDO_0002442","gene":"hgnc:493","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_dd577817-d668-413c-95f9-d3e08a8cf5d3-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}